Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
9,303.26
10,863.74
11,985.86
12,893.11
13,815.52
12,428.95
12,061.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,303.26
10,863.74
11,985.86
12,893.11
13,815.52
12,428.95
12,061.89
Raw Material Cost
6,473.95
6,813.04
7,622.90
8,223.87
8,054.69
6,834.94
6,316.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
1,307.14
1,151.38
1,136.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.30
38.90
61.97
111.54
116.22
133.11
199.61
Selling and Distribution Expenses
1,196.02
1,834.87
2,782.96
3,283.05
4,121.27
4,031.24
4,217.89
Other Expenses
39.45
48.76
45.12
33.97
-90.30
-84.69
-97.32
Total Expenditure (Excl Depreciation)
8,078.74
9,174.40
10,918.99
11,958.21
12,696.28
11,303.81
10,897.43
Operating Profit (PBDIT) excl Other Income
1224.5
1689.3000000000002
1066.9
934.9
1119.2
1125.1000000000001
1164.5
Other Income
221.04
184.81
195.47
250.29
99.24
141.20
154.53
Operating Profit (PBDIT)
2,036.83
2,487.05
1,976.96
1,938.57
2,001.35
1,974.63
2,020.82
Interest
14.30
38.90
61.97
111.54
116.22
133.11
199.61
Exceptional Items
-1.78
-10.54
1.21
0.68
-132.10
-45.73
0.46
Gross Profit (PBDT)
2,829.30
4,050.71
4,362.96
4,669.24
5,760.83
5,594.01
5,745.52
Depreciation
717.57
778.30
825.25
848.54
824.19
736.69
730.86
Profit Before Tax
1,303.18
1,659.30
1,090.96
979.17
928.85
1,059.10
1,090.82
Tax
185.42
340.97
131.95
116.63
97.06
141.08
144.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
941.60
1,083.62
691.88
627.79
568.28
648.79
656.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
941.60
1,083.62
691.88
627.79
568.28
648.79
656.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
200.56
248.46
272.73
239.69
252.87
251.25
272.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,142.17
1,332.08
964.61
867.48
821.15
900.05
928.47
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
13,778.84
13,203.92
12,388.36
10,305.44
8,592.76
8,131.21
7,587.47
Earnings per share (EPS)
0.7
0.81
0.54
0.54
0.48
0.55
0.57
Diluted Earnings per share
0.7
0.81
0.54
0.54
0.48
0.55
0.57
Operating Profit Margin (Excl OI)
11.8%
14.03%
7.98%
6.51%
7.8%
8.82%
9.41%
Gross Profit Margin
21.72%
22.44%
15.99%
14.18%
12.69%
14.45%
15.1%
PAT Margin
10.12%
9.97%
5.77%
4.87%
4.11%
5.22%
5.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -14.36% vs -9.36% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -14.26% vs 38.10% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -21.13% vs 29.23% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -63.24% vs -37.26% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Shanghai Shyndec Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
9,303.26
0
9,303.26
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,303.26
0
9,303.26
Raw Material Cost
6,473.95
0
6,473.95
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.30
0
14.30
Selling and Distribution Expenses
1,196.02
0
1,196.02
Other Expenses
39.45
0.00
39.45
Total Expenditure (Excl Depreciation)
8,078.74
0
8,078.74
Operating Profit (PBDIT) excl Other Income
1,224.52
0.00
1,224.52
Other Income
221.04
0
221.04
Operating Profit (PBDIT)
2,036.83
0
2,036.83
Interest
14.30
0
14.30
Exceptional Items
-1.78
0
-1.78
Gross Profit (PBDT)
2,829.30
0
2,829.30
Depreciation
717.57
0
717.57
Profit Before Tax
1,303.18
0
1,303.18
Tax
185.42
0
185.42
Provisions and contingencies
0
0
0.00
Profit After Tax
941.60
0
941.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
941.60
0
941.60
Share in Profit of Associates
0
0
0.00
Minority Interest
200.56
0
200.56
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,142.17
0
1,142.17
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
13,778.84
0
13,778.84
Earnings per share (EPS)
0.70
0
0.70
Diluted Earnings per share
0.70
0
0.70
Operating Profit Margin (Excl OI)
11.80%
0%
0.00
11.80%
Gross Profit Margin
21.72%
0%
0.00
21.72%
PAT Margin
10.12%
0%
0.00
10.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 930.33 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -14.36% vs -9.36% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 114.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -14.26% vs 38.10% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 181.58 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -21.13% vs 29.23% in Dec 2024
Annual - Interest
Interest 1.43 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -63.24% vs -37.26% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.80%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






